Sunday, Sep 01st
Last update06:50:01 AM GMT
Health Glance
The patients at Dr. Michael Mithoefer's clinic in South Carolina all suffer from post-traumatic stress disorder. Some are the victims of rape and child sexual abuse, others -- veterans returning home from Iraq -- bear the psychic scars of war.
They have tried other therapies before but here, under the watchful eye of Mithoefer and his staff, they're trying something new -- MDMA, better known as ecstasy, a drug that if bought on a street corner would land these patients in jail.
The most dominant country behind the agenda of Codex is the United States whose sole purpose is to benefit multinational interests like Big Pharma, Big Agribusiness, Big Chema and the like. At the latest meeting in Geneva, the U.S. recently became the chair of Codex which will facilitate an exacerbation of the distortion of health freedom and will continue the promulgation of misinformation and lies about genetically modified organism (GMOs) and nutrients while fulfilling the tacit population control agenda. The reason the U.S. continues to dominate Codex is because other countries falsely believe the U.S. possesses the latest and greatest safety technology when it comes to food and hence, whatever the U.S. asks for, its allies (E.U., Argentina, Brazil, Canada, Mexico, Australia, Malaysia, Indonesia, Japan, Singapore) follow suit nearly every time.
The most recent numbers on life expectancy around the world show that life expectancy numbers in the United States are worsening, both in absolute and relative terms - a trend that has been blamed on the large proportion of the population with inadequate health insurance.
"There should no longer be a debate," said Dave Zwiefel, editor emeritus of the Capital Times, in an opinion piece published in the Madison, Wis., newspaper. "Health coverage produces healthier citizens. It's time for the U.S. to stop tinkering around the edges, putting Band-Aids on a broken system, and face reality. We need, no, we deserve, a universal, single-payer health care system - now."
In spite of this record, an FDA advisory panel voted 5-4 against approving the drug for breast cancer. While studies have shown that Avastin shrinks breast tumors, there is no evidence that it lengthens or improves the quality of patients' lives.
When a newborn baby takes her first breath she is already contaminated with a range of chemicals... this is the finding in the latest compelling research conducted by several leading authorities in the field of health and wellbeing. Raising awareness of toxic chemicals present in our everyday environment (food additives, personal care products, cleaning products etc.) and having the understanding that these chemicals, in most cases, are absorbed directly into the blood supply is fundamental to the health and wellbeing of our children and future generations. Most shocking from these latest findings is the fact that some of the chemicals found in newborn cord blood were banned decades ago!
Cholesterol-lowering statin drugs do not provide any protection against Alzheimer's disease, according to a study conducted by researchers from the Rush University Medical Center in Chicago and published in Neurology, the journal of the American Academy of Neurology.
"This study adds to the growing evidence that statins don't lower the risk of Alzheimer's disease," lead researcher Zoe Arvanitakis said. "The study also found no association between taking statins and a slower cognitive decline among older people."
The Food and Drug Administration will begin posting every three months a list of drugs whose safety is under investigation because of complaints brought to the agency's attention by drug companies, physicians and patients.
The FDA will name the drug and the nature of the "adverse events" but will not describe their seriousness or the number of complaints received, officials said yesterday.
Page 221 of 235
